AffyXell Therapeutics
AffyXell Therapeutics develops novel mesenchymal stem cell therapies.
AffyXell Therapeutics is active in the biotechnology, therapeutics space based in Asia-Pacific (APAC), founded in 2020.
Within the biotechnology, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Asia-Pacific (APAC).
It is recorded at the Corporate_Round stage.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $8B in funding.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | corporate_round |
| Total funding | $8,000,000,000 |
Website: affyxell.com
Sign in to view the contact information we hold for AffyXell Therapeutics.
Create a free account
Create a free account